Cargando…

Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy

The aim of this study was to evaluate the impact of discordant endometrial sampling on the prognosis of patients finally diagnosed with uterine papillary serous carcinoma (UPSC) and to analyze UPSC mutational profile. Retrospective cohort study comparing outcomes of patients post-operatively diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Octeau, David, Abitbol, Jeremie, Amajoud, Zainab, Laskov, Ido, Ferenczy, Alex, Pelmus, Manuela, Eisenberg, Neta, Kessous, Roy, Matanes, Emad, Lau, Susie, Yasmeen, Amber, Lopez-Ozuna, Vanessa, Salvador, Shannon, Gotlieb, Walter H., Kogan, Liron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906727/ https://www.ncbi.nlm.nih.gov/pubmed/31867434 http://dx.doi.org/10.1016/j.gore.2019.100521

Ejemplares similares

Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors
por: Kogan, Liron, et al.
Publicado: (2018)

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
por: Matanes, Emad, et al.
Publicado: (2021)

Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer
por: López-Ozuna, Vanessa M., et al.
Publicado: (2021)

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
por: Philip, Charles-André, et al.
Publicado: (2017)

Biguanides in combination with olaparib limits tumorigenesis of drug‐resistant ovarian cancer cells through inhibition of Snail
por: Wang, Qiong, et al.
Publicado: (2019)

Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1
por: Baloch, Tahira, et al.
Publicado: (2019)

Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: A pilot project
por: Mitric, Cristina, et al.
Publicado: (2021)

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors
por: Amin, Oreekha, et al.
Publicado: (2015)

Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors
por: Marques, Maud, et al.
Publicado: (2015)

Water-Pipe Smoking Exposure Deregulates a Set of Genes Associated with Human Head and Neck Cancer Development and Prognosis
por: López-Ozuna, Vanessa M., et al.
Publicado: (2020)

Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?
por: Stern, Tomer, et al.
Publicado: (2021)

Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
por: Amit, Amnon, et al.
Publicado: (2019)

Metastatic serous endometrial carcinoma to the ureter
por: Sahl, Jessa W., et al.
Publicado: (2021)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

Review of Robotic Surgery in Gynecology—The Future Is Here
por: Lauterbach, Roy, et al.
Publicado: (2017)

Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer
por: Beauchamp, Marie-Claude, et al.
Publicado: (2010)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions
por: Furuya, Mitsuko, et al.
Publicado: (2016)

Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer
por: Jönsson, Jenny-Maria, et al.
Publicado: (2021)

Serous endometrial intraepithelial carcinoma: a case report
por: Najioui, Younesse, et al.
Publicado: (2023)

The clinico pathological features and survival in serous endometrial cancers
por: Datta, Amrita, et al.
Publicado: (2023)

Controversies in the Treatment of Early Stage Endometrial Carcinoma
por: Press, Joshua Z., et al.
Publicado: (2012)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
por: Galan, Alba, et al.
Publicado: (2023)

Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers
por: Gressel, Gregory M., et al.
Publicado: (2021)

Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
por: Donovan, Elysia, et al.
Publicado: (2018)

Successful radiotherapy for endometrial serous carcinoma with local repeated recurrence
por: Kusumoto, Shinya, et al.
Publicado: (2018)

Robotic transvaginal natural orifice transluminal endoscopic surgery for bilateral salpingo oophorectomy
por: Lowenstein, Lior, et al.
Publicado: (2020)

Serous endometrial intraepithelial carcinoma: a case series and literature review
por: Pathiraja, P, et al.
Publicado: (2013)

A multiomics comparison between endometrial cancer and serous ovarian cancer
por: Zhong, Hui, et al.
Publicado: (2020)

In search for biomarkers and potential drug targets for uterine serous endometrial cancer
por: Dinoi, Giorgia, et al.
Publicado: (2021)

Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants
por: Malham, Melissa Bou, et al.
Publicado: (2023)

Sentinel lymph node mapping in endometrial cancer: A comparison of main national and international guidelines
por: Dick, Aharon, et al.
Publicado: (2022)

Serous cavity metastasis: Evaluation of unknown primary
por: Jhala, Nirag, et al.
Publicado: (2022)

Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
por: Nakayama, Kentaro, et al.
Publicado: (2012)

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
por: Hiramatsu, Kosuke, et al.
Publicado: (2016)

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

Endometrial Serous Carcinoma Arising From Adenomyosis: A Clinico-Pathological Insight
por: Talwar, Amrita, et al.
Publicado: (2021)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance
por: Zhang, Tao, et al.
Publicado: (2021)

Dedifferentiated endometrial carcinoma arising from serous carcinoma: Diagnostic challenges and recommendations
por: Xu, Zhengfan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7tsjpm93dnkchjt95e6kafsgbs